Literature DB >> 31518172

Moment on the Lips, a Lifetime on the Lungs?: Improving Models of Group 2 Pulmonary Hypertension.

Evan L Brittain1,2, Anna R Hemnes3.   

Abstract

Entities:  

Keywords:  Editorial; metabolic syndrome; peripheral vascular diseases; right ventricles; vascular remodeling

Year:  2019        PMID： 31518172      PMCID： PMC6746245          DOI： 10.1161/CIRCRESAHA.119.315478

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  17 in total

1.  Unrecognized glucose intolerance is common in pulmonary arterial hypertension.

Authors:  Meredith E Pugh; Ivan M Robbins; Todd W Rice; James West; John H Newman; Anna R Hemnes
Journal:  J Heart Lung Transplant       Date:  2011-04-13       Impact factor: 10.247

2.  Insulin resistance in pulmonary arterial hypertension.

Authors:  R T Zamanian; G Hansmann; S Snook; D Lilienfeld; K M Rappaport; G M Reaven; M Rabinovitch; R L Doyle
Journal:  Eur Respir J       Date:  2008-12-01       Impact factor: 16.671

3.  A potential role for insulin resistance in experimental pulmonary hypertension.

Authors:  James West; Kevin D Niswender; Jennifer A Johnson; Meredith E Pugh; Linda Gleaves; Joshua P Fessel; Anna R Hemnes
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

4.  Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.

Authors:  Elke S Hoendermis; Licette C Y Liu; Yoran M Hummel; Peter van der Meer; Rudolf A de Boer; Rolf M F Berger; Dirk J van Veldhuisen; Adriaan A Voors
Journal:  Eur Heart J       Date:  2015-07-17       Impact factor: 29.983

5.  Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.

Authors:  Mario Gerges; Christian Gerges; Anna-Maria Pistritto; Marie B Lang; Pia Trip; Johannes Jakowitsch; Thomas Binder; Irene M Lang
Journal:  Am J Respir Crit Care Med       Date:  2015-11-15       Impact factor: 21.405

6.  Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study.

Authors:  Milton Packer; John McMurray; Barry M Massie; Abraham Caspi; Vincent Charlon; Alain Cohen-Solal; Wolfgang Kiowski; William Kostuk; Henry Krum; Barry Levine; Paolo Rizzon; Jordi Soler; Karl Swedberg; Susan Anderson; David L Demets
Journal:  J Card Fail       Date:  2005-02       Impact factor: 5.712

7.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

Authors:  Christian Gerges; Mario Gerges; Marie B Lang; Yuhui Zhang; Johannes Jakowitsch; Peter Probst; Gerald Maurer; Irene M Lang
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

8.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

9.  Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.

Authors:  Anna R Hemnes; Evan L Brittain; Aaron W Trammell; Joshua P Fessel; Eric D Austin; Niki Penner; Karen B Maynard; Linda Gleaves; Megha Talati; Tarek Absi; Thomas Disalvo; James West
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

10.  Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.

Authors:  Diana Bonderman; Ingrid Pretsch; Regina Steringer-Mascherbauer; Pavel Jansa; Stephan Rosenkranz; Caroline Tufaro; Andja Bojic; Carolyn S P Lam; Reiner Frey; Michael Ochan Kilama; Sigrun Unger; Lothar Roessig; Irene M Lang
Journal:  Chest       Date:  2014-11       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.